Emergence has launched the New Worlds Initiative to support the first 100 World Producers in the Open Metaverse, utilizing the $ometa token and Emergence infrastructure. This initiative aims to empower creators to collaboratively develop new worlds while retaining ownership of their intellectual property and fostering a cross-platform economy.Inaugural members include Bunshin Industries, which offers tools for creating photorealistic user-generated content, and other projects focused on decentralized anime and AI-powered gaming.
Wave Life Sciences has reported promising preliminary results from its RNA editing drug for Alpha-1 antitrypsin deficiency, showing significant protein production without serious side effects. This milestone has boosted interest in RNA editing technologies, with several companies, including ProQr and Korro, advancing their own programs. As the field evolves, challenges remain in ensuring the efficacy and safety of these therapies.
Wave Life Sciences has reported promising early results from its RNA editing treatment for alpha-1 antitrypsin deficiency (AATD), showing significant increases in AAT protein levels in two patients. This marks a milestone in therapeutic RNA editing, with no serious side effects observed. The findings have boosted investor confidence, leading to a 75% rise in Wave's shares, while GSK prepares to take over development under their partnership.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
